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Abstract
Background: General Practitioners (GPs) are responsible for primary prescribing decisions in most settings. Elderly
patients living in Advanced Care Facilities (ACFs) often have significant co-morbidities to consider when selecting
an appropriate drug therapy. Careful assessment is required when considering appropriate medication use in frail
older patients as they have multiple diseases and thus multiple medication. Many physicians seem reluctant to
discontinue other physicians’ prescriptions, resulting in further polypharmacy. Therefore it is relevant to ascertain
and synthesise the GP views from multiple settings to understand the processes that might promote appropriate
deprescribing medications in the elderly.
The aims of this study were to 1) compare and contrast behavioural factors influencing the deprescribing practices
of GPs providing care for ACF residents in two separate countries, 2) review health policy and ACF systems in each
setting for their potential impact on the prescribing of medications for an older person in residential care of the
elderly, and 3) based on these findings, provide recommendations for future ACF deprescribing initiatives.
Methods: A review and critical synthesis of qualitative data from two interview studies of knowledge, attitudes, and
behavioural practices held by GPs towards medication management and deprescribing for residents of ACFs in
Australia and Sweden was conducted.
A review of policies and health care infrastructure was also carried out to describe the system of residential aged
care in the both countries.
Results: Our study has identified that deprescribing by GPs in ACFs is a complex process and that there are
numerous barriers to medication reduction for aged care residents in both countries, both with similarities and
differences. The factors affecting deprescribing behaviour were identified and divided into: intentions, skills and
abilities and environmental factors.
Conclusions: In this study we show that the GPs’ behaviour of deprescribing in two different countries is much
dependent on the larger health care system. There is a need for more education to both GPs and ACF staff as well
as better cooperation between the different health care systems and appropriate monetary incentives for elderly
care to achieve better conditions for deprescribing practice.
Keywords: Deprescribing practice, General Practitioners, Polypharmacy, Ageing, Advanced Care Facilities, Nursing
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Background
Polypharmacy is common in frail elderly patients requir-
ing residential care, and is associated with an increased
risk of serious adverse drug effects and hospitalisation
[1, 2]. Studies in aged care facilities (ACFs) show that
polypharmacy (defined as the concomitant use of five or
more medicine) occurs in over 90 % of residents [3, 4],
with an average of 7–10 medications per person [5]. Fur-
ther, over 70 % of ACF residents take one or more po-
tentially inappropriate medication (PIM) [5] −medicines
associated with higher medical costs, increased rates of
adverse drug effects and poorer health outcomes.
Frailty is a construct originally established by gerontol-
ogists to describe cumulative declines across different
physiological systems that occur with ageing, leading to
a state of diminished physiological reserve and increased
vulnerability to stressors [6]. Different approaches to
frailty exist and different screening criteria for frailty as
a syndrome have been developed. An example of screen-
ing for frailty by Fried et al. requires the presence of a
critical mass (≥3) of the following clinical manifestations:
weakness, weight loss, slow walking speed, fatigue, and
low levels of activity [7]. This phenotype has been found
to predict various poor clinical outcomes, including
falls, the development of disability, hospitalization,
and mortality.
The term deprescribing is used to describe the process
of gradual withdrawal and ceasing of PIMs, supervised
by a health care professional and with the goal of man-
aging polypharmacy and improving outcomes [8].
Deprescribing initiatives in ACFs are not well explored
and intervention studies assessing the effectiveness of
deprescribing interventions on health, quality of life and
mortality in older people residing in aged care remain in
their infancy [9] However these studies have struggled
with the inclusion of patients, and therefore there is a
need to explore attitudes about deprescribing in different
ACF settings.
General Practitioners (GPs) are responsible for pri-
mary prescribing decisions in most settings. Elderly
patients often have significant co-morbidities to con-
sider when selecting an appropriate drug therapy.
Careful assessment is required when considering ap-
propriate medication use in frail older patients as
they have multiple diseases and thus multiple medica-
tion. There is sometimes a perceived lack of commu-
nication between GPs and other specialists concerning
their patients’ medication, and this might reduce
treatment quality [10]. Many physicians seem reluc-
tant to discontinue other physicians’ prescriptions,
resulting in further polypharmacy, and other health
care professionals address this question as beyond
their control [11]. Therefore it is relevant to ascertain
and synthesise the GP views from multiple settings to
understand the processes that might promote appro-
priate deprescribing.
Even though the systems of elderly care differ between
countries, there is a major need for in-depth research on
the work and quality of care in ACFs to recognize op-
portunities for strategic improvement and to highlight
priorities for education [12], which can be used for
deprescribing practice.
The aims of this study were to 1) compare and con-
trast behavioural factors influencing the deprescribing
practices of GPs providing care for ACF residents in two
separate countries, 2) review health policy and ACF sys-
tems in each setting for their potential impact on the
prescribing of medications for an older person in resi-
dential care of the elderly, and 3) based on these
findings, provide recommendations for future ACF
deprescribing initiatives.
Methods
A review and critical synthesis of qualitative data from
two studies of knowledge, attitudes, and behavioural
practices held by GPs towards medication management
and deprescribing for residents of ACFs in Australia and
Sweden was conducted. A qualitative approach was ad-
dressed as the point of departure consists of concrete
descriptions of experienced events from the perspective
of everyday life by the participants. The result is then a
description of underlying comprehension of the experi-
ence, interpreted for assessing knowledge that could be
significant for a wider community [13].
The methods for each study have been published else-
where [14, 15]. In brief, Study 1 (The RELEASE Study)
incorporated a focus group of eight GPs, all of who pro-
vided regular medical care to residents of ACFs in a sin-
gle region in south-eastern Australia. Study 2 (The
Swedish GP Study) involved individual semi-structured
interviews with 12 GPs working in primary health care
centers throughout the southernmost province of Skåne,
Sweden. In both of the studies the GPs were recruited
by email or newsletter announcements. The inclusion
criterion for the participating GPs was that he or she
had responsibility for patients at an ACF. The inter-
viewed GPs did not get any reward for participating in
the study, as it was based on voluntariness. The recruit-
ment of GPs as well as the interviews and the focus
group discussion with the GPs lasted until the re-
searchers felt that sampling more data would not lead to
more information related to the research question i.e.
saturation was reached.
A review of policies and health care infrastructure was
carried out to describe the system of residential aged
care in the both countries. The search was conducted on
the internet for government documents concerning the
following areas: demographics of the aged population,
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proportion of population in ACFs, number of medica-
tions per ACF resident, primary health care structure,
ACF GP workforce, funding for primary health care, GP
funding structure, and medication reviews for ACF
residents
Data analysis
The Integrative Model of Behaviour Prediction (IMBP)
[16] was chosen as the theoretical framework underpin-
ning the interpretation of findings from both studies.
The IMBP is a theoretical model used widely in health
behaviour research which predicts that intentions are
the immediate antecedents of behaviour, and recognizes
that environmental factors, skills and abilities can mod-
erate the intention-behaviour relationship. The model
also assumes that the intention to perform a specified
behaviour is a function of attitudes, perceived normative
pressure and self-efficacy [17] (Fig. 1).
The verbatim transcripts from the Australian GP
focus group and the Swedish GP interviews were read
through several times by the research team for con-
tent emersion. All researchers read the full verbatim
transcripts from the Australian study. The Swedish
study was transcribed verbatim in Swedish, why only
the first author who is Swedish-speaking could under-
stand the transcripts and then translate them into
English for the rest of the research team to read.
Findings across each study were then explored by all
members of the research team, coded and systematic-
ally collapsed under each of the key constructs of the
IMBP, focusing on the constructs of attitudes, norms,
self-efficacy, environmental factors, intent, and skills
and abilities. Themes additional to those falling within
the IMBP structure (if any) were allowed to emerge
inductively. The research team worked collaboratively
to further refine themes and compare findings according
to each study.
Results
Aged care and primary health care in Australia and Sweden
A comparison of aged care systems and policies in
Australia and Sweden is presented in Table 1.
In Sweden the medical care of ACF residents is man-
aged by the local primary health care (PHC) centre. A
single salaried GP is allocated to one ACF, provides
weekly visits to residents, and prioritises care in consult-
ation with the ACF Registered Nurse (RN). In the last
decade, intervention studies with patient focused drug
surveillance in ACFs in Sweden have showed a reduction
of the number of prescription medications per resident
[18]. Structured medication reviews are conducted regu-
larly by pharmacists in collaboration with the GP, the
RN and ACF nursing staff, and have been shown to im-
prove the appropriateness of prescribing, including the
deprescribing of unnecessary medications for older resi-
dents with multiple diseases [19]. To incentivise the re-
duction of PIMs, the Swedish government provides a
financial reward to regions that reduce PIM rates by a
given percent [20]. In the southernmost province of
Skåne (where the interviewed GPs are situated) there is
an appointed “Elderly-General”, a GP with special inter-
est in aged care and medications who assists with medi-
cation reviews and educates other GPs on deprescribing
practice.
In Australia, there are a number of different models of
GP care for residents of ACFs (http://www.racgp.org.au/
afp/2015/april/models-of-general-practitioner-services-in-
residential-aged-care-facilities/). A fall in the number of
GP consultations for residents of ACFs has been reported
and several barriers to the provision of GP services to
ACFs have been identified, including competing with the
complexity and demands of regular general practice com-
mitments, the time consuming nature of visits to ACF res-
idents, and inadequate remuneration for the work
conducted and the travel time [21]. Initiatives to increase
GP services for ACF residents include improved reim-
bursement, improved collaborative care initiatives involv-
ing allied health, and an enhanced role in palliative care.
Additional research is needed to investigate the potential
impact of innovative models of care and alternative fund-
ing methods in Australia [22].
Intention to deprescribe
According to the IMBP (Fig. 1) [17], the intention for
a GP to perform deprescribing is formed by critical
beliefs in 1. self-efficacy, 2. norms and 3. attitudes.
The themes emerging from the transcripts regarding
these beliefs are outlined below and further sum-
marised in Table 2.
Fig. 1 An Integrative Model of Behaviour Prediction, adapted from
Fishbein (2006)
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Self-efficacy in deprescribing
Self-efficacy is based on a GP’s beliefs that they are able
to carry out the processes required to deprescribe.
I deprescribe Both the Australian and Swedish GPs
expressed confidence in their ability to deprescribe.
“After 20 years I know exactly what I want to do. I
don’t have a problem with saying, yep, the Statin goes,
the Aspirin goes, the Warfarin goes.” (AusGP4)
“When a patient first arrives to the nursing home, it is
no longer ‘what to prescribe?’, but ‘what to deprescribe?’”
(SweGP5)
Insecurity In cases where the GP felt that a resident’s
medication could be replaced by nursing care, their
self-efficacy to deprescribe was lower as they
perceived a lack of support from ACF nursing staff
in “prescribing” nursing care when deprescribing
medications
“I am pretty confident in what I am doing and
what I don’t want to do. If there is a prescription
that I don’t agree with, I won’t prescribe it…But
when it comes to the discussion about non-
pharmacological issues, such as nursing care instead
of medications, it is hard to gain support from the
nursing staff.” (SweGP6)
Common to GPs from both settings was a lack of con-
fidence to deprescribe disease-specific medications with-
out the input of specialist advice. In these cases the GPs
felt isolated in their medication decision making, as con-
sulting a specialist was often difficult to initiate and time
consuming.
Table 1 Aged care systems and policies in Australia and Sweden
Australia Sweden
Population ≥65 years 15 % [21] 20 % [22]
Population ≥65 in ACF 7.8 % [23] 5 % [22]
Number of medications per ACF
resident
7–10 [3, 4, 24] 7–10 [25, 26]
(>70 % have one or more PIM)
ACF providers • Private not-for-profit [27]
• Private for-profit [27]
• Municipality (responsible)
• Private (paid by municipality) [28]
General practice structure • Single/multiple GP private practices [29]
• Small −medium business model [29]
• Team-based primary care facilities
• Most public (owned by the county councils)
• Few private (mostly owned by companies or
cooperatives) [30]
GPs in ACF • Continuity model: GP follows long-term patient
to ACF [31]
• ACF panel model: GP provides care for >2 patients
in nearby ACF [31]
• GPwSI ACF model: GP provides regular scheduled
service to large number of ACF residents [31]
• LGPT model: GP part of team-based care [31]
• ACF-based model: Single GP partners with single
ACF [31]
• County councils responsible for residents’ medical
care; generally weekly visit to ACF by one GP from
the local primary care unit [28]
Funding for primary health care • Government funded (both state-, territory- and local-)
• Fee-for-service paid directly by patients and clients
• Private health insurers
• Private charities [32]
• Funded through national and local taxation [30].
GP funding structure • Fee-for-service paid directly by patients, and/or
• Reimbursement by Government Medicare Benefits
Schedule [29]
Different funding in the 20 different county
councils [33]. In Skåne where interviewed GPs
worked [34]:
• Based on capitation for registered patients.
• Complemented with estimated ‘illness burden’
indexation
• Performance-based payments
Medication reviews for ACF
residents
• Pharmaceutical review outsourced by ACF to private
company or local pharmacist.
• Compulsory biennially as part of ACF accreditation
process [35].
• GP may request local pharmacist to undertake
medication review at any time [35].
• Funded by Government Medicare Benefits Schedule;
maximum 1 review in 12 month period.
• Undertaken by county council employed
pharmacists undertaken at any time, at least
once a year, aiming to increase quality of
medications and reduce PIMS [36].
ACF aged care facility, GP general practitioner, GPwSI ACF GPs with special interest in aged care facilities, LGPT longitudinal general practice team
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“They seem to have a pretty crappy end stage level of
Parkinson’s, but maybe it would be worse if I stopped
these tablets and so I’ll get anxious about that.”
(AusGP6)
“Sometimes I try to call a geriatrician, but there is no
easy way to contact them. It all ends up with me
writing a letter to try to get a hold of someone, because
via telephone it is just hopeless.” (SweGP9)
Evidence and know-how There were concerns in both
settings over skill development and availability of infor-
mation to allow evidence-based deprescribing. The GPs
in Sweden felt that education for deprescribing practice
was lacking and identified the need for a forum for
meeting other GPs in elderly care for discussions about
deprescribing. Australian GPs expressed worry about not
knowing enough facts for deprescribing and emphasized
the importance of educating the next generation GPs in
the care of older patients.
“I’m not clever enough to have all the statistics in my
head to be able to say, well, that Statin is stopping all
that absolute relative blah de blah, which I don’t
understand very well. So I can’t really educate the
patient off the top of my head.” (AusGP4)
“It would be a great help [with deprescribing] to have
further training and to meet with GPs in the same
situation.” (SweGP6)
Table 2 Beliefs forming a General Practitioner’s intention to deprescribe
1. Self-efficacy I deprescribe “I cease Warfarin [for] all my nursing home patients without exception because
I think it’s actively dangerous to be on Warfarin.” (AusGP4)
“As soon as a problem arises, I take a look at the medication list and figure out
which one to deprescribe.” (SweGP10)
Insecurity “Say someone was [on] Parkinsonism drugs - I would be less confident stopping
it because… I do initiate anti-Parkinsonism drugs, but not at the higher end of
them.” (AusGP6)
“And where it can be hard to gain support for examinations and follow-ups
and help with observations and so… they like to call for sedatives, when
instead there is a need of attendance and measures other than medications.”
(SweGP10)
Evidence and know-how “From a University point of view, if you could train the undergraduate to be
interested in coming to the nursing home. This is the greatest point…” (AusGP8)
“I have only had one course on elderly and medications, and that was long
ago. But I still use the notes from that class.” (SweGP1)
“Is it right or wrong to deprescribe this medication? You are pretty alone in the
decision actually. I would like some kind of mentorship or someone to talk to.”
(SweGP3)
2. Norms Unrealistic expectations “And, I think, sometimes the specialists are a bit unrealistic. Sometimes they’re a
little bit unrealistic about what’s actually going on - on the actual coalface,
I think.” (AusGP4)
“I don’t think they need some of the medications, but it is all psychology,
the psychology of the patient and of the staff. They believe somehow that
somethings would get better with pills.” (SweGP5)
The Almighty doctor “So they’re [relative] feeling guilty about the fact that they’ve [their parent] gone
into the nursing home…So the…family want them to keep on going and
going and going, so you do everything possible to keep them [resident] alive.”
(AusGP6)
“There is a focus on the doctor. And I have very little chance to help the patient
because what the patient actually is in need of is basic care …but this may
lead to that a patient gets many medications” (SweGP11)
3. Attitudes Facilitating a good quality of life “I think the medications which keep them comfortable are important, like pain
medications can help them. And those ones which are related to heart.” (AusGP5)
“…the first priority is definitely to reduce suffering, reduce anxiety…try to make
life meaningful for the patient. Diseases are secondary.” (SweGP4)
Interest and disinterest in aged care “I think that’s a big barrier for us to be able to get other doctors [to] actually
provide services there [in the aged care facility].” (AusGP6)
“It [aged care work] is sort of a relief compared to the ordinary work at the
primary health care centre, you get away from the primary health care centre
for a while every week and it is freer time, not the scheduled appointments all
the time, but you go there and sometimes you visit the patients and sometimes
you just discuss the patients. It is more free and a different way of working
with patients.” (SweGP12)
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Residents of ACFs in both countries had regular
medication reviews conducted by a pharmacist and
this was seen as a facilitator of deprescribing by the
Swedish GPs:
“I think that the quality [of prescribing decisions] has
increased greatly, and that is actually because of
Hälsovalet [government incentives of medication
reviews]… It makes my work with the elderly more
pleasant.” (SweGP3)
Australian GPs, however, were less inclined to imple-
ment the recommendations of a medication review con-
ducted by a pharmacist from external medication review
companies, who were often contracted by ACFs to con-
duct their biennial accreditation medication review:
“It’s one of those pieces of paper which goes in
the shredder for me. If I haven’t got the time to
negotiate – or to really think about the [medication
review] because medico legally it’s a document
which actually stitches you up.” (AusGP6)
Norms affecting GP-led deprescribing
The expectations of other stakeholder involved in the
care of a resident, including RNs, nursing staff and rela-
tives of residents, are often based on perceived norms
and are important influencers on a GP’s overall intent to
deprescribe.
Unrealistic expectations Both the Swedish and
Australian GPs thought that relatives, nursing staff and
residents had unrealistic views on the role and import-
ance of medications for an older person. Australian doc-
tors expressed a gap between relatives’ expectations of
care provided by an ACF, and suggested a need for dis-
cussion and acceptance of a palliative approach to the
care of ACF residents.
“In our world there is a lot of fixation on diagnoses
and diseases that should be cured. But in residential
aged care there should be another perspective – having
company, not being alone etc.” (SweGP4)
“I honestly think 90 % of relatives don’t see the nursing
homes as a palliative situation… Well, people with
medical training can, perhaps, see it for what it is.
Whereas relatives look at things often through rose-
coloured glasses and they think it’s going to get better.”
(AusGP1)
The Almighty doctor GPs from both settings perceived
pressure from relatives and nursing staff to prescribe
medications in order to try to improve a resident’s health
state, and felt this was a barrier to their attempts to
deprescribe.
“So the anxiety that the staff [and] a lot of the relatives
have about grandma dying, they’re displaced onto the
nursing staff, so the nursing staff are worried about
grandma and they’ve displaced it onto us and then that
gets displaced onto… the geriatrician” (AusGP6)
“I want to get away from giving medicines when the
reason is that there are not enough nursing staff.
There is a tendency for this, with too much focus on
the doctor.” (SweGP11)
Attitudes towards deprescribing
Facilitating a good quality of life Swedish GPs per-
ceived their role in the care of a resident as being a
facilitator of good quality, end of life care. Depre-
scribing was seen as an important component of this
approach.
“I want to give the patients a good quality of life, and I
follow them in the continuum of ageing, with their
progressive weakness and adapt medical interventions
for this.” (SweGP10)
The attitudes of the Swedish GPs seemed to be based
on their own perspectives of ageing and dependency
and how they would like to be treated in that stage
of life.
“Every time I am there I think to myself, ‘please don’t
let me end up here’.” (SweGP5)
“I have done much thinking about how I want to be
treated in that situation, and I have talked to my
relatives about it. If I get seriously ill and suffer from
dementia, please don’t fight for prolonging my life to
eternity” (SweGP2)
While there was some sentiment from Australian GPs
about a desire to assist residents to achieve the best
quality of life possible, this was often overshadowed by
discussion of perceived system-related barriers to pro-
viding care.
“So [the aim is to] to treat them, to keep them
comfortable. And, again, those who have a good
quality life, they can go out and visit their relatives,
that is just like normal management.” (AusGP5)
Interest and disinterest in aged care Interest in pro-
viding care for ACF residents differed notably between
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the GPs from the two countries. The Australian GPs
were overwhelmingly negative about aged care and
expressed dissatisfaction at the financial reimbursement
provided for ACF services. Their attitudes towards
deprescribing for ACF residents were influenced by con-
cerns of blame in the case of negative health outcomes, an
increasing workload and a general disinterest in aged care.
“I’d be very, very happy to give that to anybody who
wanted it, pay a significant amount of money to get
that off my hands. I’m completely burnt out with it.”
(AusGP4)
“In my heart I know it would have made no difference,
but I’ve had it where people – I’ve stopped the
bisphosphonate or whatever and within the week
they’ve fallen over and busted something. And the
nurses… they go, ‘oh, look’.” (AusGP6)
The Swedish GPs expressed a more positive attitude
about working in ACFs and often preferred it to their
more stressful everyday work at the PHC centre.
“It is like a relief compared to the PHC centre, that
you get to go away from the PHC centre every week
and go to the nursing home, and it also gives you an
opportunity to prioritise your work.” (SweGP12)
Behaviour of deprescribing In addition to a GP’s
intention to deprescribe, the IMBP (Fig. 1) denotes that
both environmental factors and skills and abilities will
influence whether or not this behaviour is performed.
The themes emerging from the transcripts that relate to
these two constructs are outlined below and expanded
in Table 3.
Environmental factors influencing deprescribing
Working within a complex system The administrative
load associated with ACF work was burdensome for the
GPs in both countries. Messy medication charts and
poorly integrated IT systems were seen by GPs as bar-
riers to efficient medical care. The Swedish GPs also
highlighted the onerous administrative situation with dif-
ferent employers, as the ACF is driven by the municipality
responsible for the social service and the GP is employed
by the county with responsibility of the health care.
“I hate the organisational barriers to actually being more
efficient there. I think negotiating with the nursing home
to get things done is extremely frustrating.” (AusGP6)
“The paperwork from the municipality is often not
summarized, it is time demanding work, getting it all
together, and I don’t have time for that.” (SweGP4)
The value of teamwork GPs in both settings valued
good leadership and skills in ACF nursing staff. Continu-
ity of care and clear dialogue between GP and RN was
perceived as a facilitator of deprescribing practice. The
Swedish GPs, each only committed to one ACF, engaged
regularly and effectively with the ACF’s RN. Australian
GPs also placed importance on a having a good working
relationship with ACF staff.
“Well, I cooperate with the nurse named X, and she is
very good and that makes my work much easier and
more pleasant. We can have a good dialogue and
she… I feel that she has a good clinical sense and good
intentions for the patient’s well-being.” (SweGP11)
“I’ve got two or three nursing home staff who are
fantastic. So I just don’t want make this out that
they’re all terrible and that’s the reason I’m still there.
If they leave I’m out of there. There’s no way I am
staying.” (AusGP4)
Financial incentives A major difference between the two
countries emerged in the financial arrangements for reim-
bursement of ACF-associated patient care. Australian GPs
expressed dissatisfaction with the financial incentive for
working in aged care, and felt that this was negatively
influencing younger doctors’ participation in ACF
work.
“Because they [young doctors] don’t get paid enough.”
(AusGP3)
The Swedish GPs, all employed by the government, did
not mention any financial factors influencing their work
in ACFs or their decision to deprescribe. A government-
led initiative that financially incentivises deprescribing is
currently functioning in Sweden, however this does not
directly affect individual GPs who work as fixed-salary
employees.
Skills and abilities
Quality of human resources There was dissatisfaction of
GPs from both countries with the skill level of ACF nurs-
ing staff, which they perceived as preventing appropriate
deprescribing. The GPs mentioned both level of interest
and level of education of both nursing and managerial staff
as being barriers for effective medication management.
“There is a need for better educated people who run
the ACFs” (SweGP10)
“But most [nursing staff] are very under skilled, very
unintelligent and not able to make any decisions for
themselves.” (AusGP1)
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Although there was some contradictory feelings about
this within the Australian GP group.
“And so – and some of the RNs are very skilled. But
some of the RNs are hiding in the shadows, I reckon…
“(AusGP6)
Quantity of human resources Doctors in Sweden also
expressed the need for more staff to be able to carry out a
better quality of prescribing and deprescribing practice.
“It is frustrating with the lack of nursing staff, of course.
But I can’t take responsibility for the municiptality’s
employment system, it is all political.” (SweGP2)
Discussion
Our study has identified that deprescribing by GPs in
ACFs is a complex process and that there are numerous
barriers to medication reduction for aged care residents.
GPs are not familiar with the evidence of the benefits of
deprescribing, and this may be partially due to the lack
of deprescribing trials involving participation of the frail
elderly. Whilst the harms of polypharmacy are well
known, most of the supporting data is observational and
therefore may not be sufficient to change clinical prac-
tice, particularly in a world dominated by the marketing
of medication for younger people. Despite the lacking
evidence base, there is still an important role for
education and continued professional development to
support any deprescribing initiative.
In Anderson et al’s review from 2014 [23] barriers and
enablers to deprescribe have been summarised as a
multitude of highly interdependent factors both being
intrinsic to the prescriber (eg beliefs, attitudes, know-
ledge, skills and behaviour) and being extrinsic to the
prescriber (eg. patient, work setting, health care system
and cultural factors). This is also seen in our study
shown in Fig. 2. Intrinsic factors as GPs attitudes seem
to be very much dependent on extrinsic factors as fund-
ing for the Australian GPs. Intrinsic factors as skills and
abilities for deprescribing being expressed in both coun-
tries to be hampered by the low quality in knowledge
and too low numbers of ACF staff.
The attitude and belief within the ACF (of staff, rela-
tives and residents) where medication was seen as a
common solution, was considered unrealistic by GPs in
both countries and there was a confidence in the doctor
as a problem solver of issues that are not only medical.
According to the Swedish GPs, the goal of medication
management for aged care residents was to achieve a
good quality of life, promoting as little medications as
possible. The Australian GPs were less clear with the
purpose of their commitment to aged care, with the low
financial reimbursement associated with providing care
for ACF residents dominating as a negative influence.
Among the Australian GPs, environmental factors were
evident as barriers to effective deprescribing, particularly
Table 3 Factors affecting a General Practitioner’s deprescribing behaviour
Environmental factors Working within a complex system “So lack of uniformity of medication documentation is a barrier.” (AusGP3)
“I am pretty stressed when I am come back to the PHCC from the ACF.
It limits me to not have the computer system to work with at the ACF,
therefore I have to bring back a lot of work to administrate when I come
back to the PHCC.” (SweGP6)
Communication “You’re stopping people’s blood pressure medication and then to Digoxin
and things like that. To me what that means is then unless you then
identify a palliative care situation and everybody’s happy with that,
is that means more monitoring, more faxes, more this, more that.”
(AusGP3)
“I feel that it takes a lot of patience and ability to cooperate with the
other staff at the ACF.” (SweGP2)
Financial incentives to providing care “They will all complain bitterly about the doctors because we’re
always - well, I am - always grumpy and never want to be there
because you feel like you’re virtually doing charity work because you
work hard.” (AusGP4)
Skills and ability Quality of human resources “The issue is as well is that the nursing staff have got to have the
capacity to actually adhere to the plan.” (AusGP4)
“I would like more nursing staff, better educated nursing staff.
It is my belief that we could save a lot of time and money that
way.” (SweGP2)
Quantity of human resources “The institution has to respect the [prescribing] policy and have
enough skill to actually adhere to it.” (AusGP6)
“It is not optimal that a patient gets a sedative drug instead of
someone that holds her hand, but it is as good as it can get because
there is no other way. That is frustrating of course, and sad, that I can’t
influence this in any way” (SweGP2)
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concern over administrative burden and lack of financial
incentive. GPs of both countries worried about the
shortage of staff at the ACF and their lack of medication
knowledge, and expressed that this limited the possibil-
ities of deprescribing.
The systems of financial incentive for GPs working in
aged care are different in the two countries. Participating
Swedish GPs did not mention monetary incentives when
discussing their experience with aged care services, as
their work at the ACF does not influence their overall
income or practice. Although there are incentives and
payment for ceasing PIMS as well as extra payment for
visits with multi-morbid elderly, this is provided at a sys-
tem level and does not affect the individual GP’s
monthly income or practice. The present funding model
for GP services in Australian ACFs is less supportive of
the time-commitment required to achieve meaningful
medication review. Subsequently GPs appear to prefer-
ence maintaining a resident’s medication list over initiat-
ing change. These findings suggest need for funding
reform to better support the time and resource require-
ments of deprescribing within Australian ACFs, and in-
centivise Australian GP involvement and specialisation
in aged care.
Another important difference between the two settings
studied is the model of service provision: Swedish GPs
are individually responsible for the care of all residents
of one ACF; Australian GPs may have small patient
groups across a number of different ACFs. This struc-
tural difference may have some influence on the diver-
ging attitudes of the GPs. The Swedish model of one GP
per ACF seems to favour deprescribing by promoting a
closer relationship between the RN and GP and enabling
clear communication around adverse medication effects.
The aim of enabling good quality of life in its latter
stages supported by the Swedish GPs which may be in-
formed by the overall picture the GP gets when taking
care of all residents at the ACF. The Australian GP only
responsible of a couple of residents may instead have the
approach of similar to overall general practice.
A systematic review of randomized clinical trials re-
vealed that interventions using educational outreach, on-
site education given alone or as part of an intervention
package and pharmacist medication review may under
certain circumstances reduce inappropriate drug use, but
the evidence is still limited [24] and further interventions
studies are needed with multidisciplinary approach.
Strengths and limitations
It is a strength that this study has brought together evi-
dence from GPs in different settings of the factors influen-
cing deprescribing for AFC residents. It is important to
emphasize that the results of our study are not representa-
tive of all ACFs in either setting, yet provide an illustration
of factors influencing GP deprescribing for residents
within the context of each setting. Limitations of partici-
pant selection have been previously described [14, 15].
When participating in an interview study, the GPs had
to take time off from work. This could lead to a possibil-
ity that we may have missed the GPs that did not find
the work with elderly interesting and therefore did not
want to spend extra time on interviews. This may have
been reflected in our study giving a more positive pic-
ture of the work at ACFs. Still, we believe that we have
got more information from GPs interested in the subject
than we would have got from interviewing GPs that
were not interested in the task.
Fig. 2 Barriers and facilitators to a General Practitioner’s participation in deprescribing for residents of aged care facilities
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The analysis of the results in this study was conducted
by the research team consisting of multiple professions.
In light of the fact of preconceptions of the first author
as a GP, who is involved in other NH studies, the co-
researchers (also physicians, nurse, public health re-
searcher) viewed the material in every step of the
process of analysing data to supplement each other’s
statements and interpretations in order to achieve trust-
worthiness [25] and analyst triangulation. In this study
we synthesised a qualitative study of a sample of GPs
from the south of Sweden and a qualitative study of a
sample of GPs in NSW, Australia, given that the results
are best interpreted in similar settings, but not necessar-
ily transferable to other countries where ACFs may have
a different structure. The interviewed GPs were of differ-
ing ages and had diverse types of experience which in-
creased the transferability [26].
Conclusion
Despite the high prevalence of polypharmacy along with
the known risks of adverse drug effects in frail elderly,
studies on deprescribing in this age group are limited
but has showed positive effects in the frail elderly when
drugs are withdrawn [27]. As the most vulnerable and
care needing part of the elderly population reside in
ACFs, the ACF population could be considered as frail
and the results applicable in an ACF population.
In this study we show that the GPs’ behaviour of
deprescribing in two different countries is much
dependent on the larger health care system. The short-
age of ACF staff is a barrier for adequate deprescribing
practice. There is a need for more education to both
GPs and ACF staff as well as better cooperation between
the different health care systems and appropriate monet-
ary incentives for elderly care to achieve better condi-
tions for deprescribing practice.
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